Ranga Sarangarajan

Dr. Sarangarajan is a seasoned executive with extensive expertise in both scientific research and business strategy. He has consistently created value by developing novel, proprietary pipelines of assets and products within the pharmaceutical, biotechnology, and services industries. As a pioneer and early adopter, he has developed processes for successful integrated biology, technology, and computational analytics to drive data-driven biological insights and asset creation.

He has overseen the successful translation of numerous programs across multiple scientific disciplines, from early discovery through early-stage clinical development. Dr. Sarangarajan’s has extensive experience and training in the translation of basic science to clinical applications with potential for commercial development.  This unique blend of scientific and business acumen enables him to provide strategies for prioritization of resource allocation and investments in the asset/product development process.

Dr. Sarangarajan’s career has been rooted in developing research-based asset packages that solve real-world problems with unmet needs and business challenges.  His expertise spans across pharmaceutic/biotechnology, diagnostics, health and wellness industries.  He brings a unique blend of scientific expertise and strategic acumen, having pitched to venture capital, private equity and other investors with success in both dilutive and non-dilutive funding.